David E. Morse
- Oncology top 5%
- Hematology top 5%
-
- Renal cell carcinoma treatment 3
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research 2
- Gastroenterology top 5%
- Gastrointestinal Tumor Research and Treatment 2
-
- Nicotinic Acetylcholine Receptors Study 3
-
- Smoking Behavior and Cessation 2
-
- Acute Lymphoblastic Leukemia research 2
-
- Neurotransmitter Receptor Influence on Behavior 2
-
- Stress Responses and Cortisol 1
David E. Morse
18 papers receiving 2.5k citations
Hit Papers
Peers
Comparison fields: 5 of 116
- Oncology 784
- Hematology 303
- Pulmonary and Respiratory Medicine 724
- Genetics 206
- Gastroenterology 101
Countries citing papers authored by David E. Morse
This map shows the geographic impact of David E. Morse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David E. Morse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David E. Morse more than expected).
Fields of papers citing papers by David E. Morse
This network shows the impact of papers produced by David E. Morse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David E. Morse. The network helps show where David E. Morse may publish in the future.
Co-authorship network
The 25 scholars most cited alongside David E. Morse, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 190 | |
| 2 | 2007 | 207 | |
| 3 | 2007 | 223 | |
| 4 | Approval Summary: Sunitinib for the Treatment of Imatinib Refractory or Intolerant Gastrointestinal Stromal Tumors and Advanced Renal Cell Carcinomabreakdown → | 2007 | 407 |
| 5 | 2006 | 398 | |
| 6 | 2006 | 68 | |
| 7 | 2005 | 4 | |
| 8 | 2005 | 91 | |
| 9 | 2004 | 415 | |
| 10 | Fulvestrant in postmenopausal women with advanced breast cancer. | 2003 | 46 |
| 11 | 1996 | 56 | |
| 12 | 1994 | 101 | |
| 13 | 1991 | 56 | |
| 14 | 1989 | 40 | |
| 15 | 1987 | 20 | |
| 16 | 1984 | 28 | |
| 17 | 1984 | 196 | |
| 18 | 1983 | 7 | |
| 19 | 1969 | 1 |
About David E. Morse
David E. Morse is a scholar working on Gastroenterology, Endocrine and Autonomic Systems, Behavioral Neuroscience, Periodontics and Genetics, having authored 19 papers that have together received 2.6k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (3 papers), Nicotinic Acetylcholine Receptors Study (3 papers), Chronic Lymphocytic Leukemia Research (2 papers), Smoking Behavior and Cessation (2 papers), Acute Lymphoblastic Leukemia research (2 papers), Neurotransmitter Receptor Influence on Behavior (2 papers), Gastrointestinal Tumor Research and Treatment (2 papers) and Stress Responses and Cortisol (1 paper). The work is most often cited by research in Oncology (784 citations), Hematology (303 citations), Pulmonary and Respiratory Medicine (724 citations), Genetics (206 citations) and Gastroenterology (101 citations). David E. Morse has collaborated with scholars based in United States. Frequent co-authors include Richard Pazdur, Neil E. Grunberg, Robert Justice, Rajeshwari Sridhara, Brian Booth, Sophia Abraham, Deborah J. Bowen, Ramzi Dagher, Nallaperumal Chidambaram and Vicki Goodman. Their work appears in journals such as Clinical Cancer Research, Psychopharmacology, Journal of Applied Social Psychology, Journal of Clinical Oncology and American Journal of Epidemiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.